0 items USD 0.00Search
Your search for "global markets direct diabetic macular edema pipeline review h2 2017" gave back 819845 results.
The global Diabetic Macular Edema Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Macular edema is the accumulation of fluid in the macular retina or under the retina. Macular edema is an important cause of vision loss.Diabetic...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global EYLEA Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Diabetic eye disease is a group of eye problems that can affect people with diabetes. These conditions include diabetic retinopathy, diabetic macular...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Anti-VEGF Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Retinal Biologics market size was valued at US$ million in 2023. With growing demand in downstream market, the Retinal Biologics is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Lucentis (Ranibizumab) and Biosimilar market size was valued at USD 1156.5 million in 2022 and is forecast to a readjusted size of USD 971...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
